Scorpius Holdings, Inc. (SCPX) Stock Price & Analysis
Scorpius Holdings, Inc. (SCPX) — price $0.0002 (0.00%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Scorpius Holdings, Inc. · SCPX
Scorpius Holdings Inc. operates as an integrated contract development and manufacturing organization (CDMO) through its subsidiary, Scorpius BioManufacturing. It offers a comprehensive suite of services, including analytical testing, process development, formulation, and clinical biomanufacturing, to pharmaceutical and biotechnology companies.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.0002 | |
| Change on the day | 0.00% | |
| 52-week range | $0.0001 – $0.10 | |
| Shares traded on the day | 60.8K |
Price & events
Other perspectives
Council score for Scorpius Holdings (SCPX): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Scorpius Holdings (SCPX), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Scorpius Holdings, Inc. (SCPX) is the company analyzed here. It employs 91 people and is led by Jeff A. Wolf. In Q3 FY2025 it reported revenue of $229,842 and net income of -$984,429.
What do the latest results show for Scorpius Holdings (SCPX)?
Short answer · as of
The most recent reported quarter, Q3 FY2025, carried revenue of $229,842. Against analyst estimates the company has EPS beat 2 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2025 | $229,842 | -$984,429 | -$0.02 (diluted) |
| Q2 FY2025 | $2M | -$4M | -$0.09 (diluted) |
| Q1 FY2025 | $212,264 | -$11M | -$1.16 (diluted) |
| Q4 FY2024 | $1M | -$9M | -$1.85 (diluted) |
What are the financial strengths and risks for Scorpius Holdings (SCPX)?
Short answer · as of
The distress and quality screens read Piotroski F 0. Trailing ratios: ROE 0.0% · ROA -24.4% · current ratio 0.10.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
- Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
What should you watch next at Scorpius Holdings (SCPX)?
Short answer · as of
Analyst estimates on file carry FY2026 revenue $10.00M · EPS -342.00 · 1 analysts.
What the records here don't tell us
- The next earnings date is not yet scheduled in the calendar we read.
- Fewer than two score snapshots exist, so no score trend is shown.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Revenue estimate
- $10.00M
- EPS estimate
- $-342.00
Measured against a quoted price of $0.0002 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 2
- Identified insiders
- 1
- Purchases
- 0
- Sales
- 0
- Other transactions
- 2
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held SCPX in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported SCPX in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: SCPX Stock
These answers are editorial: 1 of these 1 answer is drawn from the SCPX research dossier (written Jun 15, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.
How does Scorpius Holdings, Inc. navigate the competitive CDMO landscape?
Scorpius Holdings, Inc. navigates the competitive CDMO landscape by offering an integrated service model that spans analytical testing, process development, formulation, and clinical biomanufacturing.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 17 figures on this page — 8 from Financial Modeling Prep (FMP) and 9 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com